NCT06456177

Brief Summary

Introduction and aim: Nociception monitors have been used to assess pain management in anesthetized patients. The investigators set out to evaluate whether Nociception Level (NOL) monitor (PMD-200 monitor with NOL technology , (Medasense Biometrics Ltd. Ramat Gan, Israel) yields reliable readings during labor, and whether the derived NOL index will be associated with Visual analogue scale (VAS) subjective level of pain before and after the onset of epidural analgesia. Methods: Following approval by the intuitional review board No 0056-21-CMC, thirty parturients scheduled for epidural analgesia due to labor pains will be included in this prospective study, after informed consent for participation in the study will be obtained. NOL monitoring device will be connected to the subject finger. Epidural analgesia will be performed as per institutional standards. Data of VAS and NOL index will be collected once a minute. The association between VAS and NOL before and after the onset of adequate analgesia will be evaluated.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Jun 2021

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 30, 2021

Completed
2.9 years until next milestone

First Submitted

Initial submission to the registry

May 30, 2024

Completed
Same day until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 30, 2024

Completed
14 days until next milestone

First Posted

Study publicly available on registry

June 13, 2024

Completed
17 days until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2024

Completed
Last Updated

July 3, 2024

Status Verified

June 1, 2024

Enrollment Period

2.9 years

First QC Date

May 30, 2024

Last Update Submit

June 30, 2024

Conditions

Keywords

Epidural AnalgesiaVisual Analogue ScaleNociception Level Index

Outcome Measures

Primary Outcomes (2)

  • Evaluation of pain relief using neuroaxial epidural analgesia in parturient by Visual Analog Scale (VAS)

    The effect of pain relief using neuroaxial epidural analgesia in awake patients with intermittent painful stimuli (uterine contractions) by reporting the Visual Analog Scale (VAS) displayed as a scale from 1-10, with 0 representing no nociception and 10 representing extreme nociception, when higher scores mean a worse outcome

    60 minutes

  • Evaluation of pain relief using neuroaxial epidural analgesia in parturient by Nociception Level (NOL) index

    The effect of pain relief using neuroaxial epidural analgesia in awake patients with intermittent painful stimuli (uterine contractions) by monitoring the Nociception Level (NOL) index displayed as a scale from 0-100 with 0 representing no nociception and 100 representing extreme nociception, when higher scores mean a worse outcome.

    60 minutes

Interventions

Comparing nociception in obstetric patients during epidural analgesia, subjectively, by Visual analog scale and objectively by monitoring Nociception level Index

Eligibility Criteria

Age20 Years - 45 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Women parturient , age between 20-45 years Present pregnancy is their second, Singleton births, third trimester of pregnancy, delivery conducted under Epiduarl analgesia

You may qualify if:

  • Parturient
  • Age between 20-45 years
  • Present pregnancy istheir second
  • Singleton births
  • Under Epiduarl analgesia

You may not qualify if:

  • Age younger than 20 years or older than 45 years
  • First pregnancy
  • Multiple birth

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Carmel Medical Center

Haifa, 3436212, Israel

Location

Study Officials

  • Dana Koos, Dr. MD

    danako@clalit.org.il

    STUDY CHAIR

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Director of outpatient pain medicine clinic

Study Record Dates

First Submitted

May 30, 2024

First Posted

June 13, 2024

Study Start

June 30, 2021

Primary Completion

May 30, 2024

Study Completion

June 30, 2024

Last Updated

July 3, 2024

Record last verified: 2024-06

Locations